Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DW1029M for Microalbuminuria in Diabetic Nephropathy (Phase II)
KCT0001061Phase 2Completed
- Sponsor
- Dongwha Pharmaceutical Co., Ltd.
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DW1029M in diabetic glomerulosclerosis, sponsored by Dongwha Pharmaceutical Co., Ltd.. Started Jan 2014; status: completed.
02
Drugs
DW1029M
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on KCT0001061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001061.